Similarly, LXR activation in hepatocytes suppressed the transactivation of a subset of NASH-promoting genes by destabilizing the TAZ (WWTR1) protein level, halting the progression from steatosis to steatohepatitis [129]. This evidence concerns the gene WWTR1 and metabolic dysfunction-associated steatohepatitis.